Joint Statement By Sorrento Therapeutics, Inc. And Scilex Holding Company On Today’s Isolated Chapter 11 Filing By Sorrento Therapeutics, Inc.
Scilex Holding Company (NASDAQ:SCLX, ", Scilex", )))), a majority-owned subsidiary of Sorrento Therapeutics, Inc. (NASDAQ:SRNE, ", Sorrento", )))) and an innovative revenue-generating company focused on